Lv4
500 积分 2025-08-06 加入
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
5天前
已完结
The clinical implications of BCOR mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study
6天前
已完结
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study
9天前
已完结
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial
10天前
已完结
Predicting Induction Toxicity with 7+3: Analysis of SWOG Trial S1203
16天前
已关闭
Acute lymphocytic leukaemia
16天前
已完结
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial
18天前
已完结
Neo‐enhancers in T‐cell acute lymphoblastic Leukaemia (T‐ALL) and beyond
20天前
已完结
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
20天前
已完结
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia
20天前
已完结
皖公网安备34019202002308
